HPB Surgery Department, Royal Surrey County Hospital, Egerton Road, Guildford, Surrey, GU2 7XX, UK.
Eur J Surg Oncol. 2010 Jan;36(1):47-51. doi: 10.1016/j.ejso.2009.05.003. Epub 2009 Jun 6.
The optimal size of clear liver resection margin width in patients with colorectal liver metastases (CRLM) remains controversial. The aim of this study was to investigate the effects of margin width on long-term survival after liver resection for CRLM with a policy of standard neo-adjuvant chemotherapy.
Consecutive patients (n=238) who underwent liver resection for CRLM were included over a ten-year period. All patients with synchronous or early (<2 years) metachronous tumours were treated with neo-adjuvant chemotherapy. Data were recorded prospectively.
Overall survival of the cohort at 1, 3 and 5 years were 90.3%, 68.1% and 56.1% respectively. The incidence of cancer involved resection margins (CIRM) was 5.8%. Patients with macroscopically involved resection margins had a poorer overall survival than those with microscopically involved margins (p=0.04). Involved resection margins had a poorer overall survival (p=0.002) than patients with clear margins. Width of clear resection margin did not affect long-term survival.
CIRM independently predicts poor outcome in patients with CRLM. Clear margin width does not affect survival. A standard policy of neo-adjuvant chemotherapy may be associated with a low incidence of CIRM and improved long-term outcome of sub-centimetre margin widths, resembling those with >1cm resection margins.
在接受结直肠癌肝转移(CRLM)标准新辅助化疗的患者中,肝切除切缘无肿瘤残留宽度的最佳大小仍存在争议。本研究旨在探讨在接受新辅助化疗的 CRLM 患者中,切缘宽度对肝切除后长期生存的影响。
在十年期间纳入了连续接受肝切除术治疗 CRLM 的患者(n=238)。所有同步或早期(<2 年)异时性肿瘤患者均接受新辅助化疗。前瞻性地记录数据。
该队列的总体生存率在 1、3 和 5 年分别为 90.3%、68.1%和 56.1%。癌症累及切缘(CIRM)的发生率为 5.8%。与显微镜下累及切缘的患者相比,肉眼累及切缘的患者总体生存率较差(p=0.04)。累及切缘的患者总体生存率较差(p=0.002),明显差于无肿瘤累及切缘的患者。切缘无肿瘤残留宽度并不影响长期生存。
CIRM 独立预测 CRLM 患者的不良预后。无肿瘤累及切缘的宽度不影响生存。标准的新辅助化疗方案可能与 CIRM 的发生率低以及亚厘米宽度切缘的长期预后改善相关,类似于>1cm 切缘宽度的患者。